Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritisRobin P. Boushey, Daniel J. Drucker, Bernardo Yusta|American Journal of Physiology-Endocrinology and Metabolism|1999Cited by 178
Human [Gly<sup>2</sup>]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitisDaniel J. Drucker, Patricia L. Brubaker, Bernardo Yusta et al.|American Journal of Physiology-Gastrointestinal and Liver Physiology|1999Cited by 174
Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.Robin P. Boushey, Daniel J. Drucker, Bernardo Yusta|PubMed|2001Cited by 150
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammationChi Kin Wong, Daniel J. Drucker, Bernardo Yusta et al.|Cell Metabolism|2022Cited by 121
The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent PathwayBernardo Yusta, Daniel J. Drucker, Robin P. Boushey|Journal of Biological Chemistry|2000Cited by 114